HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ulgiati, D. Articles by Holers, V. M. Search for Related Content PubMed PubMed Citation Articles by Ulgiati, D. Articles by Holers, V. M.

CR2/CD21 Proximal Promoter Activity Is Critically Dependent on a Cell Type-Specific Repressor¹

Daniela Ulgiati and V. Michael Holers^2,*,

^* Departments of Immunology and Medicine, and Division of Rheumatology, University of Colorado Health Sciences Center, Denver, CO 80262

Transcription of the human complement receptor type 2 (CR2/CD21) gene is controlled by both proximal promoter and intronic elements. CR2 is primarily expressed on B cells from the immature through mature cell stages. We have previously described the presence of an intronic element that is required for both cell- and stage-specific expression of CR2. In this study, we report the identification of a cell type-specific repressor element within the proximal promoter. This repressor sequence is shown by linker scanning mutagenesis to comprise an E box motif. By supershift analysis this element binds members of the basic helix-loop-helix family of proteins, in particular E2A gene products. Mutational analysis demonstrates that binding of E2A proteins is critical for functioning of this repressor. Thus, E2A activity is key not only for early B cell development, but also for controlling CR2 expression, a gene expressed only during later stages of ontogeny.

This article has been cited by other articles:

				I. Debnath, K. M. Roundy, J. J. Weis, and J. H. Weis Defining In Vivo Transcription Factor Complexes of the Murine CD21 and CD23 Genes J. Immunol., June 1, 2007; 178(11): 7139 - 7150. [Abstract] [Full Text] [PDF]

				H. Wu, S. A. Boackle, P. Hanvivadhanakul, D. Ulgiati, J. M. Grossman, Y. Lee, N. Shen, L. J. Abraham, T. R. Mercer, E. Park, et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus PNAS, March 6, 2007; 104(10): 3961 - 3966. [Abstract] [Full Text] [PDF]

				H.-g. Hu, H. Illges, C. Gruss, and R. Knippers Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes Int. Immunol., June 1, 2005; 17(6): 789 - 796. [Abstract] [Full Text] [PDF]

				H. Chang, Y. Gwack, D. Kingston, J. Souvlis, X. Liang, R. E. Means, E. Cesarman, L. Hutt-Fletcher, and J. U. Jung Activation of CD21 and CD23 Gene Expression by Kaposi's Sarcoma-Associated Herpesvirus RTA J. Virol., April 15, 2005; 79(8): 4651 - 4663. [Abstract] [Full Text] [PDF]

				S. Greenbaum, A. S. Lazorchak, and Y. Zhuang Differential Functions for the Transcription Factor E2A in Positive and Negative Gene Regulation in Pre-B Lymphocytes J. Biol. Chem., October 22, 2004; 279(43): 45028 - 45035. [Abstract] [Full Text] [PDF]

				M. Tolnay, L. A. Vereshchagina, and G. C. Tsokos NF-{kappa}B Regulates the Expression of the Human Complement Receptor 2 Gene J. Immunol., December 1, 2002; 169(11): 6236 - 6243. [Abstract] [Full Text] [PDF]

				D. Ulgiati, C. Pham, and V. M. Holers Functional Analysis of the Human Complement Receptor 2 (CR2/CD21) Promoter: Characterization of Basal Transcriptional Mechanisms J. Immunol., June 15, 2002; 168(12): 6279 - 6285. [Abstract] [Full Text] [PDF]